Magnetically responsive layer-by-layer microcapsules can be retained in cells and under flow conditions to promote
Jordan E Read1, Dong Luo, Tina T Chowdhury
1Centre for Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK. d.j.gould@qmul.ac.uk.
Nanoscale
|March 27, 2020
Summary
Superparamagnetic iron oxide nanoparticles (SPIONs) incorporated into layer-by-layer (LbL) microcapsules enable magnetic retention at disease sites. This biocompatible approach enhances local drug delivery by preventing premature clearance and prolonging drug release.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Nanoengineered vehicles face challenges in drug delivery due to immune clearance and lymphatic drainage.
- Superparamagnetic iron oxide nanoparticles (SPIONs) offer potential for targeted manipulation and retention of drug carriers.
Purpose of the Study:
- To investigate the use of SPIONs within layer-by-layer (LbL) microcapsules for magnetic retention at a delivery site.
- To evaluate the biocompatibility and drug release characteristics of SPION-loaded LbL structures.
Main Methods:
- SPIONs were incorporated into LbL microcapsules and dexamethasone-loaded microcrystals.
- Cellular assays assessed phagocytosis, ROS synthesis, and cell viability.
- Magnetic field application evaluated microcapsule retention under flow conditions and shear stress.
- Drug release kinetics were measured using a glucocorticoid-sensitive reporter cell line.
Main Results:
- SPION-loaded microcapsules were biocompatible, not inducing ROS or affecting cell viability.
- A magnetic field effectively retained SPION-containing LbL structures under physiologic shear stress, even at low SPION concentrations.
- Dexamethasone-loaded LbL structures with SPIONs demonstrated prolonged drug release exceeding 30 hours.
Conclusions:
- SPIONs can be effectively used for magnetic retention of LbL structures, enhancing local drug delivery.
- This SPION-mediated magnetic retention strategy is biocompatible and feasible for targeted therapeutic applications.
- The prolonged drug release profile indicates potential for improved treatment efficacy in localized disease management.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...


